Short Interest in Astera Labs, Inc. (NASDAQ:ALAB) Increases By 25.6%

Astera Labs, Inc. (NASDAQ:ALAB) saw a large growth in short interest in the month of March. As of March 13th, there was short interest totaling 13,516,520 shares, a growth of 25.6% from the February 26th total of 10,763,918 shares. Based on an average trading volume of 4,874,844 shares, the short-interest ratio is presently 2.8 days. Approximately 9.1% of the company’s stock are sold short.

Astera Labs Trading Down 10.8%

Astera Labs stock opened at $100.27 on Tuesday. Astera Labs has a 1-year low of $47.13 and a 1-year high of $262.90. The firm has a market capitalization of $17.17 billion, a price-to-earnings ratio of 82.19, a price-to-earnings-growth ratio of 2.21 and a beta of 1.75. The firm’s fifty day moving average price is $136.67 and its two-hundred day moving average price is $161.96.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same period in the previous year, the firm posted $0.37 earnings per share. The firm’s revenue for the quarter was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts forecast that Astera Labs will post 0.34 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Northland Securities increased their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Citigroup decreased their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Finally, Loop Capital began coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $202.22.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 157,500 shares of Astera Labs stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00. Following the completion of the sale, the chief executive officer directly owned 4,531,732 shares of the company’s stock, valued at approximately $596,285,296.56. The trade was a 3.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Sanjay Gajendra sold 94,971 shares of Astera Labs stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the sale, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. This trade represents a 5.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 384,292 shares of company stock worth $48,724,919 over the last ninety days. 12.50% of the stock is owned by corporate insiders.

Institutional Trading of Astera Labs

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada lifted its holdings in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares in the last quarter. AQR Capital Management LLC grew its holdings in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares in the last quarter. Empowered Funds LLC grew its holdings in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares in the last quarter. Creative Planning raised its position in Astera Labs by 37.6% in the 2nd quarter. Creative Planning now owns 13,368 shares of the company’s stock valued at $1,209,000 after buying an additional 3,656 shares during the last quarter. Finally, Cetera Investment Advisers raised its position in Astera Labs by 167.1% in the 2nd quarter. Cetera Investment Advisers now owns 9,131 shares of the company’s stock valued at $826,000 after buying an additional 5,712 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.